Description
GLYPIN Tablets 4 mg – 28’s
GLYPIN 4 mg Tablets contain Vildagliptin 4 mg, a DPP-4 (dipeptidyl peptidase-4) inhibitor indicated for the management of type 2 diabetes mellitus. Vildagliptin enhances the body’s incretin system, leading to increased insulin secretion and decreased glucagon levels in response to meals, thereby improving overall glycemic control.
This strength may be part of a specialized or region-specific formulation. While Vildagliptin is typically prescribed in 50 mg or 100 mg per day (as per global guidelines), if GLYPIN 4 mg is regionally approved, it may represent a unique dosing standard or combination product. Please consult with a healthcare provider to confirm appropriate dosing.
GLYPIN is often used as monotherapy for patients intolerant to Metformin or as part of combination therapy with other oral antidiabetics or insulin. It is well-tolerated, with a low risk of hypoglycemia and neutral effect on body weight.
Key Features:
-
Contains 4 mg Vildagliptin per tablet
-
DPP-4 inhibitor: improves insulin response and reduces glucagon
-
Supports postprandial and fasting glucose control
-
Low hypoglycemia risk and weight neutral
-
Suitable for monotherapy or in combination with other agents
-
Pack of 28 tablets for a standard 4-week course
Usage:
Take exactly as prescribed by your doctor. Always follow your physician’s guidance on dosing and regular glucose monitoring.
Reviews
There are no reviews yet.